Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02682251 · ClinicalTrials.gov registry record · NA
Engaging Patients in Heart Failure Management
A NA study, sponsored by Parkview Health.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT02682251 is a NA study that has completed, run by Parkview Health. The registered enrollment target is 10 participants.
The verdict
NCT02682251, a NA study, has completed, sponsored by Parkview Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
An interventional study to empower congestive heart failure patients who have a cardiac resynchronization therapy-cardiac implantable electronic device (CRT-CIED) by using a personal health record (PHR) to directly message them their device data and send alerts based on percent left ventricular pacing.
Interventions
- OTHER PHR Messaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2016-02 |
| Est. Completion | 2019-10-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02682251
The ClinicalTrials.gov registry entry for NCT02682251 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Parkview Health, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which PHR Messaging is the first listed.
NCT02682251 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02682251 about?
NCT02682251 is a clinical study titled "Engaging Patients in Heart Failure Management". An interventional study to empower congestive heart failure patients who have a cardiac resynchronization therapy-cardiac implantable electronic device (CRT-CIED) by using a personal health record (PHR) to directly message them their device data and send alerts based on percent left ventricular paci...
What is the current status of trial NCT02682251?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2016-02. Estimated completion is 2019-10-05.
What interventions are being tested in trial NCT02682251?
The interventions under investigation include: PHR Messaging (OTHER).
Who is sponsoring clinical trial NCT02682251?
This trial is sponsored by Parkview Health, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.